| Dr Jackie D Maxey, MD | |
|
102 Professional Dr, Suite #2, London, KY 40741-8857 | |
| (606) 878-9611 | |
| (606) 862-7565 |
| Full Name | Dr Jackie D Maxey |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 25 Years |
| Location | 102 Professional Dr, London, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073525861 | NPI | - | NPPES |
| 64009913 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 35548 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Vna Health At Home 1 | London, KY | Home health agency |
| Professional Home Health Care, Inc | London, KY | Home health agency |
| Manchester Memorial Hospital | Manchester, KY | Hospital |
| Baptist Health Corbin | Corbin, KY | Hospital |
| Saint Joseph London | London, KY | Hospital |
| Laurel Heights Home For The Elderly | London, KY | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Memorial Hospital, Inc. | 4486616141 | 42 |
News Archive
Scientists and researchers at the U.S. Naval Research Laboratory and National Center for Advancing Translational Sciences, submitted their findings to ACS Nano, a monthly peer-reviewed scientific journal, on their collaboration to develop SARS-CoV-2 nanoparticle probes that are used to study fundamental interactions between SARS-CoV-2 Spike proteins and human cells.
Researchers from UCLA's Jonsson Comprehensive Cancer Center report that a new drug in preliminary tests has shown promising results with very manageable side effects for treating patients with melanoma, the deadliest form of skin cancer.
Four of Iowa's premier health care organizations announced today they are creating a health care alliance in Iowa and contiguous areas. The announcement was made in a statewide press conference, held today in several cities simultaneously.
TrialScope, the global leader in clinical trial transparency and compliance solutions, today announced general availability of the latest release of the PharmaCM platform (v.2.2) that automates and manages clinical trial results reporting via the European Medicines Agency's European Clinical Trials Database (EudraCT).
› Verified 9 days ago
| Entity Name | Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831150119 PECOS PAC ID: 4486616141 Enrollment ID: O20041103001183 |
News Archive
Scientists and researchers at the U.S. Naval Research Laboratory and National Center for Advancing Translational Sciences, submitted their findings to ACS Nano, a monthly peer-reviewed scientific journal, on their collaboration to develop SARS-CoV-2 nanoparticle probes that are used to study fundamental interactions between SARS-CoV-2 Spike proteins and human cells.
Researchers from UCLA's Jonsson Comprehensive Cancer Center report that a new drug in preliminary tests has shown promising results with very manageable side effects for treating patients with melanoma, the deadliest form of skin cancer.
Four of Iowa's premier health care organizations announced today they are creating a health care alliance in Iowa and contiguous areas. The announcement was made in a statewide press conference, held today in several cities simultaneously.
TrialScope, the global leader in clinical trial transparency and compliance solutions, today announced general availability of the latest release of the PharmaCM platform (v.2.2) that automates and manages clinical trial results reporting via the European Medicines Agency's European Clinical Trials Database (EudraCT).
› Verified 9 days ago
| Entity Name | Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255471827 PECOS PAC ID: 4486616141 Enrollment ID: O20141210002155 |
News Archive
Scientists and researchers at the U.S. Naval Research Laboratory and National Center for Advancing Translational Sciences, submitted their findings to ACS Nano, a monthly peer-reviewed scientific journal, on their collaboration to develop SARS-CoV-2 nanoparticle probes that are used to study fundamental interactions between SARS-CoV-2 Spike proteins and human cells.
Researchers from UCLA's Jonsson Comprehensive Cancer Center report that a new drug in preliminary tests has shown promising results with very manageable side effects for treating patients with melanoma, the deadliest form of skin cancer.
Four of Iowa's premier health care organizations announced today they are creating a health care alliance in Iowa and contiguous areas. The announcement was made in a statewide press conference, held today in several cities simultaneously.
TrialScope, the global leader in clinical trial transparency and compliance solutions, today announced general availability of the latest release of the PharmaCM platform (v.2.2) that automates and manages clinical trial results reporting via the European Medicines Agency's European Clinical Trials Database (EudraCT).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jackie D Maxey, MD Po Box 1676, London, KY 40743-1676 Ph: (606) 878-9611 | Dr Jackie D Maxey, MD 102 Professional Dr, Suite #2, London, KY 40741-8857 Ph: (606) 878-9611 |
News Archive
Scientists and researchers at the U.S. Naval Research Laboratory and National Center for Advancing Translational Sciences, submitted their findings to ACS Nano, a monthly peer-reviewed scientific journal, on their collaboration to develop SARS-CoV-2 nanoparticle probes that are used to study fundamental interactions between SARS-CoV-2 Spike proteins and human cells.
Researchers from UCLA's Jonsson Comprehensive Cancer Center report that a new drug in preliminary tests has shown promising results with very manageable side effects for treating patients with melanoma, the deadliest form of skin cancer.
Four of Iowa's premier health care organizations announced today they are creating a health care alliance in Iowa and contiguous areas. The announcement was made in a statewide press conference, held today in several cities simultaneously.
TrialScope, the global leader in clinical trial transparency and compliance solutions, today announced general availability of the latest release of the PharmaCM platform (v.2.2) that automates and manages clinical trial results reporting via the European Medicines Agency's European Clinical Trials Database (EudraCT).
› Verified 9 days ago
Dr. Robert Sidney Reffner, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 105 Villas Ct Apt 40, London, KY 40741 Phone: 423-339-9499 | |
Ryan Farris, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 272 London Mountain View Dr, London, KY 40741 Phone: 606-877-2850 Fax: 606-877-2857 | |
Shelley Bundy Stanko, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 City Hill Dr, London, KY 40741 Phone: 606-877-2050 Fax: 606-877-2080 | |
Dr. Peter T Rock, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 2645 N Laurel Rd, London, KY 40741 Phone: 606-843-6195 Fax: 606-843-6222 | |
Dr. Jarred Jones, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 175 City Hill Dr, London, KY 40741 Phone: 606-877-2050 | |
Farhan Javaid, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1406 W 5th St, Suite 201, London, KY 40741 Phone: 606-330-2377 Fax: 606-330-2369 |